Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Janssen-Cilag Ltd.

Home Clinical Trial Sponsors and OrganizationsJanssen-Cilag Ltd.

Janssen-Cilag Ltd.

ACTIVE

United Kingdomwww.janssen.comSubsidiary

Part of 强生

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

36

4 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 4

8

22.2%

Phase 3

7

19.4%

Phase 1

1

2.8%

Trial Status Distribution

Active, not recruiting

4

11.1%

Completed

24

66.7%

Recruiting

3

8.3%

Terminated

4

11.1%

Withdrawn

1

2.8%

Clinical Trials

Trials sponsored by this organization (36)

A Study of Guselkumab Treatment Persistence in Psoriatic Arthritis Participants

Apr 2026200 participants

A Study of Guselkumab After Switching From Ustekinumab in Participants With Moderate to Severe Psoriasis

Feb 20269 participants

A Study to Observe Real-world Evidence of Guselkumab Treatment in Participants With Ulcerative Colitis and Crohn's Disease in the United Kingdom (UK)

Nov 2025220 participants

A Real-world Study in Participants With Smoldering Multiple Myeloma

May 2024408 participants

A Study of Participants With Moderate or Severe Major Depressive Disorder (MDD) Requiring Urgent Symptom Control in a Psychiatric Emergency

Apr 2024220 participants

Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients

Active, not recruiting

Apr 2024120 participants

A Study of Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With T-cell Redirectors Outside of Clinical Trials

Dec 2023900 participants

A Study for the Participants With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Treated With Androgen Deprivation Therapy (ADT) Plus Apalutamide or Enzalutamide

Jul 2023505 participants

Page 1 of 5

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials36
Approvals
News

Back to Organizations